AVBP   $21.955  -3.96% Market Closed After Close 22.018 0.29%

ArriVent BioPharma, Inc.
Total Cash 298.67M
totalCashPerShare 8.893
EBITDA
Total Debt 250.00K
quickRatio 24.749
currentRatio 25.501
Total Revenue
debtToEquity 0.084
Revenue/Share
ROA -0.21224001
ROE -0.31028
grossProfits
freeCashflow -46.73M
operatingCashflow -68.07M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 735.35M
forwardPE -11.032258
floatShares 16.08M
sharesOutstanding 33.59M
sharesShort 3.41M
sharesShortPriorMonth 1.86M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.65%
Short Ratio help_outline 8.28%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 8.853
Price To Book help_outline 3.48
earningsQuarterlyGrowth
netIncomeToCommon -74.89M
trailingEps -2.23%
forwardEps -2.79%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.0 3Q 2024
institutionsCount 85
lastUpdated Nov. 2, 2024, 7:05 a.m.